Clinical Trial Update: To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial results update for perampanel (E2007) as adjunctive therapy in refractory partial-onset seizures, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial-onset Seizures

Drugs mentioned

• Perampanel (perampanel)

Snippet

Sponsor: Eisai Inc. | Conditions: Refractory Partial Seizures | Phase 3 | Status: COMPLETED | Results posted: 2012-11-22